U.S. Markets closed

J&J accepts $2.1 billion bid for its LifeScan diabetes business

Angelica LaVito

Johnson & Johnson has accepted a $2.1 billion offer for LifeScan from private equity firm Platinum Equity. J&J announced in March it received the offer. J&J said last year it would close its Animas business and exit the insulin pump market.